|Received:||7/7/2006 10:54:06 AM|
|Subject:||Business Opportunity Rule|
|Title:||Notice of Proposed Rulemaking|
|CFR Citation:||16 CFR Part 437|
Comments:Let me begin by saying what I understand what is most of the problem in the presentation of any independent business opportunity. There has always been much room for speculation as to the POSSIBLE end result of using any business strategy. So, there are many unscrupulous individuals who will overstate the end result. Example: Income-$,$$$’s, free time, etc... Also, there are the same, and others who will understate the amount of work. Example: How much effort, where the $,$$$’s come from, who does the work, where and how this WORK has to be done, etc... This all presupposes that some significant amount of result can be seen and actually accomplished and not that the result is a narrow amount from a very few with some sort of specific talent or strategic positioning.. I happen to be involved in the Business opportunity powered by Quixtar. It is a fact that I have been told that the FTC oversees us because of the sheer amount of $,$$$ which actually does change hands, which is in the BILLIONS, and if it proposes any rule it should put its’ stamp of approval or at the least acknowledge that it has its eye on and is monitoring our activity and NOT always in a negative sense with negative results. Plus some of the figures we use are so low as to make the real money makers smile, while regular folk from the average ‘ Joe’ home have some hope that things may be better for them. I once asked an individual who was commenting on the business/pyramid type money generating schemes about the Amway/Quixtar situation and I think his answer (he was not and is not involved with Amway/Quixtar ) hits the nail on the head, “...yes, but, with Amway there is real product being bought by real people and they pay for some thing the get. Some of these others is only money changing hands.” and some get nothing. You cannot legislate to protect people from the arbitrary and is your (the FTC) case load, percentage wise, more about Amway/Quixtar or others? If not, a statement, as such, not an endorsement per se can go a long in clarifying much mis understanding, however, if you can’t do it we will definitely understand.